Categories: Entertainment

NYSE Content Update: Canada-Based MDA Space Shoots for the Stars in its NYSE Debut

NYSE issues a pre-market daily advisory direct from the trading floor.

- Advertisement -

NEW YORK, March 12, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Kristen Scholer delivers the pre-market update on March 12th

- Advertisement -
  • Equities remain volatile Thursday morning as oil prices stay elevated amid the conflict in the Middle East.
  • MDA Space (NYSE: MDA) CEO Mike Greenley will ring the opening bell on NYSE Live to celebrate the company’s listing.
  • Fintech Revolut recently acquired a full UK banking license after starting the application process in 2021.
  • U.S. Figure Skating power couple Madison Chock and Evan Bates will have a Bell Moment after Olympic glory in Milan.

Opening Bell
MDA Space (NYSE: MDA) celebrates its IPO

- Advertisement -

Closing Bell
Vulcan Materials (NYSE: VMC) celebrates nearly 70 years on the NYSE

- Advertisement -

For market insights, IPO activity, and today’s opening bell, download the NYSE TV App: TV.NYSE.com

- Advertisement -

 

- Advertisement -

Video – https://mma.prnewswire.com/media/2932601/NYSE_March_12_Market_Update.mp4 
Photo – https://mma.prnewswire.com/media/2932600/NYSE_Costamare_Bulkers.jpg 
Logo – https://mma.prnewswire.com/media/2581322/5861061/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-update-canada-based-mda-space-shoots-for-the-stars-in-its-nyse-debut-302712351.html

- Advertisement -
PRNW Agency

Recent Posts

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

12 minutes ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

12 minutes ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

13 minutes ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

13 minutes ago